Voquezna (vonoprazan) is a prescription drug used in ... pylori infection, as dual therapy • Voquezna: 20 mg twice daily (morning and evening) for 14 days • amoxicillin: 1,000 mg three times ...

Phathom Pharmaceuticals recently announced that the FDA had approved its new drug, Voquezna (vonoprazan), to treat ... 10 ...

Pharmaceutical company Lupin has announced a non-exclusive patent licence agreement with Takeda Pharmaceutical for the ...

The US regulator has cleared two therapies based on Phathom's acid blocker vonoprazan in combination with antibiotics for Helicobacter pylori infections , which are associated with peptic ulcer ...